Organogenesis Holdings (ORGO) Stock Statistics & Valuation Metrics

Organogenesis Holdings has a market cap or net worth of $440.18M. The enterprise value is $486.99M.

Organogenesis Holdings has 126,853,540 shares outstanding. The number of shares has decreased by -2.65% in one year.

Organogenesis Holdings’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.09%.

The current PE Ratio of Organogenesis Holdings is 489.38. Organogenesis Holdings’s PEG ratio is -0.27.

In the last 12 months, Organogenesis Holdings had revenue of 482.04M and earned 861.00K in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was 4.43M and capital expenditures -11.44M, giving a free cash flow of -7.00M billion.

Organogenesis Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Organogenesis Holdings upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.

Organogenesis Holdings as a current ratio of 3.69, with Debt / Equity ratio of 46.60%

In the past 12 months, Organogenesis Holdings has paid -3.67M in taxes.

Organogenesis Holdings EV to EBITDA ratio is 20.88, with an EV/FCF ratio of 78.81.

Organogenesis Holdings has $109.97M in cash and marketable securities with $42.63M in debt, giving a net cash position of -$67.33M billion.

Gross margin is 76.71%, with operating margin of -0.27%, and net profit margin of 0.18%.

The average price target for Organogenesis Holdings is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy